Hyloris Reports Positive Phase 1 Data for HY-004, a proprietary Tranexamic Acid Oral Mouth Rinse for bleeding related to dental procedures
Hyloris Reports Positive Phase 1 Data for HY-004, a proprietary Tranexamic Acid Oral Mouth Rinse…
Hyloris Reports Positive Phase 1 Data for HY-004, a proprietary Tranexamic Acid Oral Mouth Rinse…
Internet City, Dubai–(Newsfile Corp. – July 20, 2022) – LBank Exchange, a global digital asset…
TOKYO, Jul 20, 2022 – (JCN Newswire) – Mitsubishi Heavy Industries Engineering, Ltd. (MHIENG), a…
FARNBOROUGH, United Kingdom, Jul 20, 2022 – (JCN Newswire) – Mitsubishi Heavy Industries, Ltd (MHI)…
PETALING JAYA, Malaysia, Jul 20, 2022 – (ACN Newswire) – UCrest Berhad (ACE Market: 0005)…
HONG KONG, Jul 20, 2022 – (ACN Newswire) – Organised by the Hong Kong Trade…
REDWOOD CITY, Calif., July 19, 2022 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a…
TOKYO, Jul 20, 2022 – (JCN Newswire) – The LCR Honda CASTROL Team are pleased…
TOKYO, Jul 20, 2022 – (JCN Newswire) – ENEOS Corporation (ENEOS), Suzuki Motor Corporation (Suzuki),…
ADELAIDE, AUS, Jul 20, 2022 – (ACN Newswire) – TrialWire(TM) Technology Platform, the most secure…
NEW YORK, Jul 20, 2022 – (ACN Newswire) – NexBloc today announced that Ankit Sahni…
Field trials have resulted in significant improvement, while leaving minimal footprint TEL AVIV, Israel–(BUSINESS WIRE)–ICL…
TOKYO–(BUSINESS WIRE)–#AI–Renesas Electronics Corporation (TSE:6723), a premier supplier of advanced semiconductor solutions, today announced the…
Itron Engage Provides Partners with Tools, Training and Support for Itron’s Solutions LIBERTY LAKE, Wash.–(BUSINESS…
MILPITAS, Calif.–(BUSINESS WIRE)–SolarEdge Technologies, Inc. (Nasdaq: SEDG), a global leader in smart energy technology, will…
SALT LAKE CITY, July 19, 2022 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a…
– Rapid and significant increase in plasma pyrophosphate (PPi) levels observed in all three subjects…
LBS-008 (a/k/a Tinlarebant) is the Company’s orally administered tablet for the treatment of Stargardt disease…
– Trial Did Not Meet Statistical Significance on Improvement in Primary Endpoints of Progression Free…
REDWOOD CITY, Calif., July 19, 2022 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a…